TY - JOUR
T1 - An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
AU - Mukherji, Atish
AU - Jühling, Frank
AU - Simanjuntak, Yogy
AU - Crouchet, Emilie
AU - Del Zompo, Fabio
AU - Teraoka, Yuji
AU - Haller, Alexandre
AU - Baltzinger, Philippe
AU - Paritala, Soumith
AU - Rasha, Fahmida
AU - Fujiwara, Naoto
AU - Gadenne, Cloé
AU - Slovic, Nevena
AU - Oudot, Marine A.
AU - Durand, Sarah C.
AU - Ponsolles, Clara
AU - Schuster, Catherine
AU - Zhuang, Xiaodong
AU - Holmes, Jacinta
AU - Yeh, Ming Lun
AU - Abe-Chayama, Hiromi
AU - Heikenwälder, Mathias
AU - Sangiovanni, Angelo
AU - Iavarone, Massimo
AU - Colombo, Massimo
AU - Foung, Steven K.H.
AU - McKeating, Jane A.
AU - Davidson, Irwin
AU - Yu, Ming Lung
AU - Chung, Raymond T.
AU - Hoshida, Yujin
AU - Chayama, Kazuaki
AU - Lupberger, Joachim
AU - Baumert, Thomas F.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Chronic liver disease and cancer are global health challenges. The role of the circadian clock as a regulator of liver physiology and disease is well established in rodents, however, the identity and epigenetic regulation of rhythmically expressed genes in human disease is less well studied. Here we unravel the rhythmic transcriptome and epigenome of human hepatocytes using male human liver chimeric mice. We identify a large number of rhythmically expressed protein coding genes in human hepatocytes of male chimeric mice, which includes key transcription factors, chromatin modifiers, and critical enzymes. We show that hepatitis C virus (HCV) infection, a major cause of liver disease and cancer, perturbs the transcriptome by altering the rhythmicity of the expression of more than 1000 genes, and affects the epigenome, leading to an activation of critical pathways mediating metabolic alterations, fibrosis, and cancer. HCV-perturbed rhythmic pathways remain dysregulated in patients with advanced liver disease. Collectively, these data support a role for virus-induced perturbation of the hepatic rhythmic transcriptome and pathways in cancer development and may provide opportunities for cancer prevention and biomarkers to predict HCC risk.
AB - Chronic liver disease and cancer are global health challenges. The role of the circadian clock as a regulator of liver physiology and disease is well established in rodents, however, the identity and epigenetic regulation of rhythmically expressed genes in human disease is less well studied. Here we unravel the rhythmic transcriptome and epigenome of human hepatocytes using male human liver chimeric mice. We identify a large number of rhythmically expressed protein coding genes in human hepatocytes of male chimeric mice, which includes key transcription factors, chromatin modifiers, and critical enzymes. We show that hepatitis C virus (HCV) infection, a major cause of liver disease and cancer, perturbs the transcriptome by altering the rhythmicity of the expression of more than 1000 genes, and affects the epigenome, leading to an activation of critical pathways mediating metabolic alterations, fibrosis, and cancer. HCV-perturbed rhythmic pathways remain dysregulated in patients with advanced liver disease. Collectively, these data support a role for virus-induced perturbation of the hepatic rhythmic transcriptome and pathways in cancer development and may provide opportunities for cancer prevention and biomarkers to predict HCC risk.
UR - https://www.scopus.com/pages/publications/85202904798
U2 - 10.1038/s41467-024-51698-8
DO - 10.1038/s41467-024-51698-8
M3 - Article
C2 - 39209804
AN - SCOPUS:85202904798
SN - 2041-1723
VL - 15
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 7486
ER -